# US 2025/0084488 A1 · Drain fluid for diagnostics

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0084488 A1
- Document ID: US20250084488A1
- Status: Published application
- Kind: A1
- Application number: 18/958,592
- Filed: 2024-11-25
- Published: 2025-03-13
- Earliest claimed: 2021-09-20
- Assignees: Droplet Biosciences, Inc.; Washington University
- Applicants: Droplet Biosciences Inc.; The Washington University
- Inventors: Jose P. Zevallos; Aadel Chaudhuri; Stanley N. Lapidus
- Web page: https://patentgrep.com/patent/US20250084488A1

## CPC

- C12Q 1/6886: for cancer (immunoassay for cancer G01N33/575)
- C12Q 1/6883: for diseases caused by alterations of genetic material
- G01N 33/57585: {involving compounds identifiable in body fluids}
- C12Q 2600/156: Polymorphic or mutational markers
- C12Q 2600/158: Expression markers
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention provides methods for testing surgical fluid for biomarkers of disease, including cancer.

## Claims

### Claim 1

A method for disease diagnosis, the method comprising the steps of:
obtaining drain fluid from a medical intervention;
identifying in the drain fluid a biomarker indicative of disease; and
diagnosing a disease or condition based on the presence of the biomarker in the drain fluid.

### Claim 2 (depends on 1)

The method of claim 1, wherein the fluid is a surgical drain fluid.

### Claim 3 (depends on 1)

The method of claim 1, wherein the fluid comprises lymphatic fluid, lymphovascular fluid, interstitial fluid or a combination thereof.

### Claim 4 (depends on 1)

The method of claim 1, further comprising the step of obtaining a genomic profile from material in the fluid.

### Claim 5 (depends on 2)

The method of claim 2, further comprising the step of separating the lymphatic fluid from the drain fluid.

### Claim 6 (depends on 1)

The method of claim 1, wherein the obtaining step comprises irrigating the surgical wound.

### Claim 7 (depends on 1)

The method of claim 1, wherein said biomarker is selected from a nucleic acid, a protein, a bacterium, a cell, and a virus.

### Claim 8 (depends on 7)

The method of claim 7, wherein said cell is a cancer cell.

### Claim 9 (depends on 1)

The method of claim 1, wherein said biomarker is a ratio of circulating tumor cells to cell-free DNA.

### Claim 10 (depends on 1)

The method of claim 1, wherein an amount of said biomarker is compared to an amount in blood or lymph node.

### Claim 11 (depends on 1)

The method of claim 1, wherein the drain fluid is obtained using a catheter or a drain port.

### Claim 12 (depends on 1)

The method of claim 1, wherein the biomarker comprises one or more of interleukin-1, interleukin-6, interleukin-10, a tumor necrosis factor, matrix metalloproteinase-1, matrix metalloproteinase-2, matrix metalloproteinase-9, matrix metalloproteinase-13, or a nucleic acid comprising a mutation.

### Claim 13 (depends on 12)

The method of claim 12, wherein the step of diagnosing a disease or condition comprises diagnosing cancer, and wherein the method further comprises the steps of:
obtaining a representative sample of lymphatic fluid; and
assaying for a cancer biomarker in said representative sample.

### Claim 14 (depends on 13)

The method of claim 13, further comprising the step of comparing the presence of the cancer biomarker in the representative sample with the presence of the biomarker in the drain fluid.
